Last mentioned: Apr 30, 2026
Anticipated Filing
Expected regulatory submission for WVE-N531 in Duchenne muscular dystrophy.
Data Review
Health authorities begin reviewing uptake rates and digital health records.
Peak Delivery Phase
High-volume vaccination sessions scheduled to capture maximum student participation.
Rollout Launch
Vaccination clinics open on campus for the first cohort of 5,000 students.
Public Health Mobilization
Coordinated media briefings and emergency triage protocols established in affected regions.
Strain Confirmation
Laboratory results confirm Meningitis B as the causative agent in two fatal cases.
National Alert Issued
Health chiefs issue an 'unprecedented' warning to the NHS network.
Initial Cluster Detection
Regional health boards report unusual spikes in bacterial meningitis cases.
Outbreak Detected
Initial cases reported with severe symptoms; public health investigation launched.
FY 2025 Earnings
Wave and Collegium release full-year financial results and 2026 guidance.
RNA Editing Milestone
WVE-006 demonstrates successful RNA editing in AATD patients.
DMD Breakthrough
Wave reports industry-leading dystrophin expression for WVE-N531.
Vaccine Integration
UK becomes first to add MenB vaccine (Bexsero) to routine infant schedule.
A large-scale public health initiative has launched to vaccinate 5,000 university students against meningitis, addressing a critical risk demographic in communal living environments. The rollout marks a significant push by health authorities to prevent outbreaks during the peak academic season.
Health authorities are mobilizing to contain a rapidly escalating meningitis outbreak characterized as 'explosive' and 'unprecedented.' The surge is forcing a massive reallocation of public health resources and a critical review of current vaccination protocols.
Health authorities have confirmed that Meningitis B is the strain responsible for a recent outbreak that has resulted in two fatalities. The identification triggers immediate public health protocols, including targeted vaccination and antibiotic prophylaxis for close contacts to prevent further spread.
A new feasibility study indicates that maternal immunization programs can be successfully integrated into existing antenatal care frameworks, provided systemic gaps are addressed. Key challenges include cold chain logistics, healthcare worker training, and the need for digital tracking systems to monitor neonatal outcomes.
The CDC has issued a series of travel notices for popular international tourist destinations following a spike in polio detections. The move signals a shift in global health security, requiring travelers to verify immunization status and potentially seek adult boosters before departure.
Wave Life Sciences and Collegium Pharmaceutical released their Q4 and full-year 2025 results, highlighting a pivotal year for RNA editing and specialty pain management. Wave's transition toward a commercial-stage biotech is accelerated by its GSK partnership and landmark clinical data in Alpha-1 antitrypsin deficiency.
This page surfaces every story mentioning GSK across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where GSK was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |